| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
-Hydroxylase1
Division of Medical Sciences, University of Birmingham, Birmingham, United Kingdom B15 2TH
Address all correspondence and requests for reprints to: Dr. Martin Hewison, Division of Medical Sciences, Queen Elizabeth Hospital, University of Birmingham, Edgbaston, Birmingham, United Kingdom B15 2TH. E-mail: m.hewsion{at}bham.ac.uk
The mitochondrial enzyme 25-hydroxyvitamin
D3-1
-hydroxylase (1
-hydroxylase) plays an important
role in calcium homeostasis by catalyzing synthesis of the active form
of vitamin D, 1,25-dihydroxyvitamin D3, in the kidney.
However, enzyme activity assays indicate that 1
-hydroxylase is also
expressed in a variety of extrarenal tissues; recent cloning of cDNAs
for 1
-hydroxylase in different species suggests that a similar gene
product is found at both renal and extrarenal sites. Using specific
complementary ribonucleic acid probes and antisera to 1
-hydroxylase,
we have previously reported the distribution of messenger ribonucleic
acid and protein for the enzyme along the mouse and human nephron. Here
we describe further immunohistochemical and Western blot analyses that
detail for the first time the extrarenal distribution of
1
-hydroxylase in both normal and diseased tissues. Specific staining
for 1
-hydroxylase was detected in skin (basal keratinocytes, hair
follicles), lymph nodes (granulomata), colon (epithelial cells and
parasympathetic ganglia), pancreas (islets), adrenal medulla, brain
(cerebellum and cerebral cortex), and placenta (decidual and
trophoblastic cells). Further studies using psoriatic skin highlighted
overexpression of 1
-hydroxylase throughout the dysregulated stratum
spinosum. Increased expression of skin 1
-hydroxylase was also
associated with sarcoidosis. In lymph nodes and skin from these
patients 1
-hydroxylase expression was observed in cells positive for
the surface antigen CD68 (macrophages). The data presented here confirm
the presence of protein for 1
-hydroxylase in several extrarenal
tissues, such as skin, placenta, and lymph nodes. The function of this
enzyme at novel extrarenal sites, such as adrenal medulla, brain,
pancreas, and colon, remains to be determined. However, the discrete
patterns of staining in these tissues emphasizes a possible role for
1
-hydroxylase as an intracrine modulator of vitamin D function in
peripheral tissues.
This article has been cited by other articles:
![]() |
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Liu, L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison Altered Endocrine and Autocrine Metabolism of Vitamin D in a Mouse Model of Gastrointestinal Inflammation Endocrinology, October 1, 2008; 149(10): 4799 - 4808. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Chlon, D. A. Taffany, J. Welsh, and M. J. Rowling Retinoids Modulate Expression of the Endocytic Partners Megalin, Cubilin, and Disabled-2 and Uptake of Vitamin D-Binding Protein in Human Mammary Cells J. Nutr., July 1, 2008; 138(7): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ng, J. A. Meyerhardt, K. Wu, D. Feskanich, B. W. Hollis, E. L. Giovannucci, and C. S. Fuchs Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer J. Clin. Oncol., June 20, 2008; 26(18): 2984 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Fleet, C. Gliniak, Z. Zhang, Y. Xue, K. B. Smith, R. McCreedy, and S. A. Adedokun Serum Metabolite Profiles and Target Tissue Gene Expression Define the Effect of Cholecalciferol Intake on Calcium Metabolism in Rats and Mice J. Nutr., June 1, 2008; 138(6): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rejnmark, P. Vestergaard, L. Heickendorff, and L. Mosekilde Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis D. Eur. J. Endocrinol., April 1, 2008; 158(4): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. McCann and B. N. Ames Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J, April 1, 2008; 22(4): 982 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study Carcinogenesis, January 1, 2008; 29(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bushinsky and P. Messa Efficacy of Early Treatment with Calcimimetics in Combination with Reduced Doses of Vitamin D Sterols in Dialysis Patients NDT Plus, January 1, 2008; 1(suppl_1): i18 - i23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rowling, C. Gliniak, J. Welsh, and J. C. Fleet High Dietary Vitamin D Prevents Hypocalcemia and Osteomalacia in CYP27B1 Knockout Mice J. Nutr., December 1, 2007; 137(12): 2608 - 2615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Freedman, A. C. Looker, S.-C. Chang, and B. I. Graubard Prospective Study of Serum Vitamin D and Cancer Mortality in the United States J Natl Cancer Inst, November 7, 2007; 99(21): 1594 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Alpert and U. Shaikh The Effects of Vitamin D Deficiency and Insufficiency on the Endocrine and Paracrine Systems Biol Res Nurs, October 1, 2007; 9(2): 117 - 129. [Abstract] [PDF] |
||||
![]() |
C. N. Holick, J. L. Stanford, E. M. Kwon, E. A. Ostrander, S. Nejentsev, and U. Peters Comprehensive Association Analysis of the Vitamin D Pathway Genes, VDR, CYP27B1, and CYP24A1, in Prostate Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1990 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bai, D. Miao, D. Goltzman, and A. C. Karaplis Early Lethality in Hyp Mice with Targeted Deletion of Pth Gene Endocrinology, October 1, 2007; 148(10): 4974 - 4983. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Kimball, M. R Ursell, P. O'Connor, and R. Vieth Safety of vitamin D3 in adults with multiple sclerosis Am. J. Clinical Nutrition, September 1, 2007; 86(3): 645 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knight, M. Lesosky, H. Barnett, J. M. Raboud, and R. Vieth Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 422 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, Y. Liu, L. A. Williams, and D. de Zeeuw Potential role of active vitamin D in retarding the progression of chronic kidney disease Nephrol. Dial. Transplant., February 1, 2007; 22(2): 321 - 328. [Full Text] [PDF] |
||||
![]() |
M. van Driel, M. Koedam, C. J. Buurman, M. Hewison, H. Chiba, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen Evidence for auto/paracrine actions of vitamin D in bone: 1{alpha}-hydroxylase expression and activity in human bone cells FASEB J, November 1, 2006; 20(13): 2417 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rowling, C. M. Kemmis, D. A. Taffany, and J. Welsh Megalin-Mediated Endocytosis of Vitamin D Binding Protein Correlates with 25-Hydroxycholecalciferol Actions in Human Mammary Cells J. Nutr., November 1, 2006; 136(11): 2754 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Stolzenberg-Solomon, R. Vieth, A. Azad, P. Pietinen, P. R. Taylor, J. Virtamo, and D. Albanes A Prospective Nested Case-Control Study of Vitamin D Status and Pancreatic Cancer Risk in Male Smokers Cancer Res., October 15, 2006; 66(20): 10213 - 10219. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knight, C. M. Vachon, R. A. Vierkant, R. Vieth, J. R. Cerhan, and T. A. Sellers No association between 25-hydroxyvitamin d and mammographic density. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1988 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui and T. E. Rohan Vitamin d, calcium, and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A Bischoff-Ferrari, E. Giovannucci, W. C Willett, T. Dietrich, and B. Dawson-Hughes Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am. J. Clinical Nutrition, July 1, 2006; 84(1): 18 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Ogunkolade, B. J. Boucher, S. A. Bustin, J. M. Burrin, K. Noonan, N. Mannan, and G. A. Hitman Vitamin D Metabolism in Peripheral Blood Mononuclear Cells Is Influenced by Chewing "Betel Nut" (Areca catechu) and Vitamin D Status J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2612 - 2617. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Vigano, D Lattuada, S Mangioni, L Ermellino, M Vignali, E Caporizzo, P Panina-Bordignon, M Besozzi, and A M Di Blasio Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J. Mol. Endocrinol., June 1, 2006; 36(3): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Bikle For Whom the Bugs Toll; They Toll for D IBMS BoneKEy, April 1, 2006; 3(4): 12 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kemmis, S. M. Salvador, K. M. Smith, and J. Welsh Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3 J. Nutr., April 1, 2006; 136(4): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Khadzkou, P. Buchwald, G. Westin, H. Dralle, G. Akerstrom, and P. Hellman 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase and Vitamin D Receptor Expression in Papillary Thyroid Carcinoma J. Histochem. Cytochem., March 1, 2006; 54(3): 355 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Garland, F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr, and M. F. Holick The Role of Vitamin D in Cancer Prevention Am J Public Health, February 1, 2006; 96(2): 252 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Vanhooke, J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. DeLuca CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin PNAS, January 3, 2006; 103(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Matusiak, G. Murillo, R. E. Carroll, R. G. Mehta, and R. V. Benya Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase in Normal and Malignant Human Colon Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2370 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
G A Clines and T A Guise Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Diesel, J. Radermacher, M. Bureik, R. Bernhardt, M. Seifert, J. Reichrath, U. Fischer, and E. Meese Vitamin D3 Metabolism in Human Glioblastoma Multiforme: Functionality of CYP27B1 Splice Variants, Metabolism of Calcidiol, and Effect of Calcitriol Clin. Cancer Res., August 1, 2005; 11(15): 5370 - 5380. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. John, G. G. Schwartz, J. Koo, D. Van Den Berg, and S. A. Ingles Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Risk of Advanced Prostate Cancer Cancer Res., June 15, 2005; 65(12): 5470 - 5479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ren, L. Nguyen, S. Wu, C. Encinas, J. S. Adams, and M. Hewison Alternative Splicing of Vitamin D-24-Hydroxylase: A NOVEL MECHANISM FOR THE REGULATION OF EXTRARENAL 1,25-DIHYDROXYVITAMIN D SYNTHESIS J. Biol. Chem., May 27, 2005; 280(21): 20604 - 20611. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Somjen, Y. Weisman, F. Kohen, B. Gayer, R. Limor, O. Sharon, N. Jaccard, E. Knoll, and N. Stern 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds Circulation, April 5, 2005; 111(13): 1666 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Welsh Vitamin D and breast cancer: insights from animal models Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1721S - 1724S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Fleet Genomic and proteomic approaches for probing the role of vitamin D in health Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1730S - 1734S. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R Greer Issues in establishing vitamin D recommendations for infants and children Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1759S - 1762S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Fleet Rapid, Membrane-Initiated Actions of 1,25 Dihydroxyvitamin D: What Are They and What Do They Mean? J. Nutr., December 1, 2004; 134(12): 3215 - 3218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Bikle Vitamin D and Skin Cancer J. Nutr., December 1, 2004; 134(12): 3472S - 3478S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ebert, M. Jovanovic, M. Ulmer, D. Schneider, J. Meissner-Weigl, J. Adamski, and F. Jakob Down-Regulation by Nuclear Factor {kappa}B of Human 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Promoter Mol. Endocrinol., October 1, 2004; 18(10): 2440 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, H. Taylor, D. Zehnder, M. D. Kilby, J. N. Bulmer, F. Shah, J. S. Adams, and M. Hewison Increased Expression of 25-Hydroxyvitamin D-1{alpha}-Hydroxylase in Dysgerminomas: A Novel Form of Humoral Hypercalcemia of Malignancy Am. J. Pathol., September 1, 2004; 165(3): 807 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
M T Abreu, V Kantorovich, E A Vasiliauskas, U Gruntmanis, R Matuk, K Daigle, S Chen, D Zehnder, Y-C Lin, H Yang, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density Gut, August 1, 2004; 53(8): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yuan, Y. Xing, R. L. Horst, and M. K. Drezner Evidence for Abnormal Translational Regulation of Renal 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Activity in the Hyp-Mouse Endocrinology, August 1, 2004; 145(8): 3804 - 3812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spach, L. B. Pedersen, F. E. Nashold, T. Kayo, B. S. Yandell, T. A. Prolla, and C. E. Hayes Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis Physiol Genomics, July 8, 2004; 18(2): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, J. N. Bulmer, M. D. Kilby, and M. Hewison Vitamin D and Placental-Decidual Function Reproductive Sciences, July 1, 2004; 11(5): 263 - 271. [Abstract] [PDF] |
||||
![]() |
G. G. Schwartz, D. Eads, A. Rao, S. D. Cramer, M. C. Willingham, T. C. Chen, D. P. Jamieson, L. Wang, K. L. Burnstein, M. F. Holick, et al. Pancreatic cancer cells express 25-hydroxyvitamin D-1{alpha}-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3 Carcinogenesis, June 1, 2004; 25(6): 1015 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Cross, E. Kallay, D. Lechner, W. Gerdenitsch, H. Adlercreutz, and H. J. Armbrecht Phytoestrogens and Vitamin D Metabolism: A New Concept for the Prevention and Therapy of Colorectal, Prostate, and Mammary Carcinomas J. Nutr., May 1, 2004; 134(5): 1207S - 1212S. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, R. B. Hayes, N. Chatterjee, W. Shao, R. E. Schoen, P. Pinsky, B. W. Hollis, K. A. McGlynn, and the Prostate, Lung, Colorectal and Ovarian Cancer Circulating Vitamin D Metabolites, Polymorphism in Vitamin D Receptor, and Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 546 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokomura, T. Suda, S. Sasaki, N. Inui, K. Chida, and H. Nakamura Increased Expression of the 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Gene in Alveolar Macrophages of Patients with Lung Cancer J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5704 - 5709. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Welsh, J. A. Wietzke, G. M. Zinser, B. Byrne, K. Smith, and C. J. Narvaez Vitamin D-3 Receptor as a Target for Breast Cancer Prevention J. Nutr., July 1, 2003; 133(7): 2425S - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hewison, L. Freeman, S. V. Hughes, K. N. Evans, R. Bland, A. G. Eliopoulos, M. D. Kilby, P. A. H. Moss, and R. Chakraverty Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells J. Immunol., June 1, 2003; 170(11): 5382 - 5390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ogose, H Kawashima, O Morita, T Hotta, H Umezu, and N Endo Increase in serum 1,25-dihydroxyvitamin D and hypercalcaemia in a patient with inflammatory myofibroblastic tumour J. Clin. Pathol., April 1, 2003; 56(4): 310 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hanley Puzzling vitamin D results Can. Med. Assoc. J., October 15, 2002; 167(8): 849 - 850. [Full Text] [PDF] |
||||
![]() |
D. Zehnder, K. N. Evans, M. D. Kilby, J. N. Bulmer, B. A. Innes, P. M. Stewart, and M. Hewison The Ontogeny of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Expression in Human Placenta and Decidua Am. J. Pathol., July 1, 2002; 161(1): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Segersten, P. Correa, M. Hewison, P. Hellman, H. Dralle, T. Carling, G. Akerstrom, and G. Westin 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Expression in Normal and Pathological Parathyroid Glands J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2967 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Janssen, M. M Samson, and H. J. Verhaar Vitamin D deficiency, muscle function, and falls in elderly people Am. J. Clinical Nutrition, April 1, 2002; 75(4): 611 - 615. [Full Text] [PDF] |
||||
![]() |
D. Zehnder, R. Bland, R. S. Chana, D. C. Wheeler, A. J. Howie, M. C. Williams, P. M. Stewart, and M. Hewison Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines: A Novel Autocrine Determinant of Vascular Cell Adhesion J. Am. Soc. Nephrol., March 1, 2002; 13(3): 621 - 629. [Abstract] [Full Text] [PDF] |